The early use of inhaled nitric oxide in premature infants requiring respiratory support

References

• Frostell C, Fratacci MD, Wain JC, et al. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991;83(6):1–5. doi: 10.1161/01.cir.83.6.2038.
   PubMed Web of Science ®Google Scholar
• Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997;336(9):597–604.
   PubMed Web of Science ®Google Scholar
• Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical inhaled nitric oxide research group. N Engl J Med. 2000;342(7):469–474. doi: 10.1056/NEJM200002173420704.
   PubMed Web of Science ®Google Scholar
• Kinsella JP, Truog WE, Walsh WF, et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 1997;131(1 Pt 1):55–62. doi: 10.1016/s0022-3476(97)70124-0.
   PubMed Web of Science ®Google Scholar
• Roberts JDJr., Fineman JR, Morin FC3rd, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med. 1997;336(9):605–610. doi: 10.1056/NEJM199702273360902.
   PubMed Web of Science ®Google Scholar
• Kinsella JP, Walsh WF, Bose CL, et al. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet. 1999;354(9184):1061–1065. doi: 10.1016/s0140-6736(99)03558-8.
   PubMed Web of Science ®Google Scholar
• Schreiber MD, Gin-Mestan K, Marks JD, et al. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med. 2003;349(22):2099–2107. doi: 10.1056/NEJMoa031154.
   PubMed Web of Science ®Google Scholar
• Mestan KK, Marks JD, Hecox K, et al. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med. 2005;353(1):23–32. doi: 10.1056/NEJMoa043514.
   PubMed Web of Science ®Google Scholar
• Ballard RA, Truog WE, Cnaan A, et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med. 2006;355(4):343–353. doi: 10.1056/NEJMoa061088.
   PubMed Web of Science ®Google Scholar
• Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med. 2006;355(4):354–364. doi: 10.1056/NEJMoa060442.
   PubMed Web of Science ®Google Scholar
• Cole FS, Alleyne C, Barks JD, et al. NIH consensus development conference statement: inhaled nitric-oxide therapy for premature infants. Pediatrics. 2011;127(2):363–369. doi: 10.1542/peds.2010-3507.
   PubMed Web of Science ®Google Scholar
• Allen MC, Donohue P, Gilmore M, et al. Inhaled nitric oxide in preterm infants. Evidence Report/Technology Assessment 195; 2010. p. 1–315.
   Google Scholar
• Kumar P, Committee on Fetus and Newborn; American Academy of Pediatrics. Use of inhaled nitric oxide in preterm infants. Pediatrics. 2014;133(1):164–170. doi: 10.1542/peds.2013-3444.
   PubMed Web of Science ®Google Scholar
• Barrington KJ, Finer N, Pennaforte T, et al. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2017;1(1):CD000399. doi: 10.1002/14651858.CD000399.pub3.
   PubMedGoogle Scholar
• Stenger MR, Slaughter JL, Kelleher K, et al. Hospital variation in nitric oxide use for premature infants. Pediatrics. 2012;129(4):e945–e951. doi: 10.1542/peds.2011-1809.
   PubMed Web of Science ®Google Scholar
• Peluso AM, Othman HF, Karnati S, et al. Epidemiologic evaluation of inhaled nitric oxide use among neonates with gestational age less than 35 weeks. Pediatr Pulmonol. 2022;57(2):427–434. doi: 10.1002/ppul.25775.
   PubMed Web of Science ®Google Scholar
• Use and misuse of inhaled nitric oxide in very low birth weight infants; 2023. Available from: https://public.vtoxford.org/nicu-by-the-numbers/use-and-misuse-of-inhaled-nitric-oxide-in-very-low-birth-weight-infants/
   Google Scholar
• Hughes Driscoll CA, Davis NL, Miles M, et al. A quality improvement project to improve evidence-based inhaled nitric oxide use. Respir Care. 2018;63(1):20–27. doi: 10.4187/respcare.05619.
   PubMed Web of Science ®Google Scholar
• Rogerson CM, Tori AJ, Hole AJ, et al. Reducing unnecessary nitric oxide use: a hospital-wide, respiratory therapist-driven quality improvement project. Respir Care. 2021;66(1):18–24. doi: 10.4187/respcare.08347.
   PubMed Web of Science ®Google Scholar
• Fischer H, Singh T, Devlin L, et al. A quality improvement project improving the value of iNO utilization in preterm and term infants. J Perinatol. 2021;41(1):164–172. doi: 10.1038/s41372-020-0768-0.
   PubMed Web of Science ®Google Scholar
• Abman SH, Hansmann G, Archer SL, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015;132(21):2037–2099. doi: 10.1161/CIR.0000000000000329.
   PubMed Web of Science ®Google Scholar
• Kinsella JP, Steinhorn RH, Krishnan US, et al. Recommendations for the use of inhaled nitric oxide therapy in premature newborns with severe pulmonary hypertension. J Pediatr. 2016;170:312–314. doi: 10.1016/j.jpeds.2015.11.050.
   PubMed Web of Science ®Google Scholar
• Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant. 2019;38(9):879–901. doi: 10.1016/j.healun.2019.06.022.
   PubMed Web of Science ®Google Scholar
• Steurer MA, Jelliffe-Pawlowski LL, Baer RJ, et al. Persistent pulmonary hypertension of the newborn in late preterm and term infants in California. Pediatrics. 2017;139(1):e20161165. doi: 10.1542/peds.2016-1165.
   PubMed Web of Science ®Google Scholar
• Nakanishi H, Suenaga H, Uchiyama A, et al. Persistent pulmonary hypertension of the newborn in extremely preterm infants: a Japanese cohort study. Arch Dis Child Fetal Neonatal Ed. 2018;103(6):F554–F561. doi: 10.1136/archdischild-2017-313778.
   PubMed Web of Science ®Google Scholar
• Mourani PM, Sontag MK, Younoszai A, et al. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2015;191(1):87–95. doi: 10.1164/rccm.201409-1594OC.
   PubMed Web of Science ®Google Scholar
• Park GY, Park WS, Sung SI, et al. Neonatal outcome comparisons between preterm infants with or without early pulmonary hypertension following prolonged preterm premature rupture of membranes before 25 gestational weeks in Korean Neonatal Network. J Matern Fetal Neonatal Med. 2022;35(7):1286–1294. doi: 10.1080/14767058.2020.1749590.
   PubMed Web of Science ®Google Scholar
• Kinsella JP, Ivy DD, Abman SH. Ontogeny of NO activity and response to inhaled NO in the developing ovine pulmonary circulation. Am J Physiol. 1994;267(5 Pt 2):H1955–H1961. doi: 10.1152/ajpheart.1994.267.5.H1955.
   PubMedGoogle Scholar
• Geary C, Whitsett J. Inhaled nitric oxide for oligohydramnios-induced pulmonary hypoplasia: a report of two cases and review of the literature. J Perinatol. 2002;22(1):82–85. doi: 10.1038/sj.jp.7210580.
   PubMedGoogle Scholar
• Chock VY, Van Meurs KP, Hintz SR, et al. Inhaled nitric oxide for preterm premature rupture of membranes, oligohydramnios, and pulmonary hypoplasia. Am J Perinatol. 2009;26(4):317–322. doi: 10.1055/s-0028-1104743.
   PubMed Web of Science ®Google Scholar
• Mullaly R, McCallion N, El-Khuffash A. Inhaled nitric oxide in preterm neonates with preterm prelabour rupture of membranes, a systematic review. Acta Paediatr. 2023;112(3):358–371. doi: 10.1111/apa.16596.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Togari H, Potenziano JL, et al. Efficacy of inhaled nitric oxide in neonates with hypoxic respiratory failure and pulmonary hypertension: the Japanese experience. J Perinat Med. 2018;46(6):657–663. doi: 10.1515/jpm-2017-0040.
   PubMed Web of Science ®Google Scholar
• Nelin L, Kinsella JP, Courtney SE, et al. Use of inhaled nitric oxide in preterm vs term/near-term neonates with pulmonary hypertension: results of the PaTTerN registry study. J Perinatol. 2022;42(1):14–18. doi: 10.1038/s41372-021-01252-x.
   PubMed Web of Science ®Google Scholar
• Rhine WD, Suzuki S, Potenziano JL, et al. An analysis of time to improvement in oxygenation in Japanese preterm and late preterm or term neonates with hypoxic respiratory failure and pulmonary hypertension. Clin Ther. 2019;41(5):910–919. doi: 10.1016/j.clinthera.2019.03.008.
   PubMed Web of Science ®Google Scholar
• Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Pediatrics. 1997;99(6):838–845.
   PubMed Web of Science ®Google Scholar
• James AT, Corcoran JD, McNamara PJ, et al. The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension. Cardiol Young. 2016;26(1):90–99. doi: 10.1017/S1047951114002698.
   PubMed Web of Science ®Google Scholar
• Mohamed AA, Louis D, Surak A, et al. Vasopressin for refractory persistent pulmonary hypertension of the newborn in preterm neonates – a case series. J Matern Fetal Neonatal Med. 2022;35(8):1475–1483. doi: 10.1080/14767058.2020.1757642.
   PubMed Web of Science ®Google Scholar
• King BC, Hagan J, Richardson T, et al. Hospital variation in neonatal echocardiography among very preterm infants at US children’s hospitals. J Perinatol. 2023;43(2):181–186. doi: 10.1038/s41372-022-01522-2.
   PubMed Web of Science ®Google Scholar